Centene Corp. consensus picture on Wall Street, shares trade on the NYSE

Centene Corp. opens Tuesday with a steady analyst consensus on Wall Street, as the managed-care provider’s shares continue to trade on the NYSE. The focus for retail investors is on earnings expectations, valuation metrics and positioning in the U.S. health insurance peer group.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 10:30.

Centene Corp. (US15133V1035) starts Tuesday with its shares listed on the NYSE in New York, where the group trades as a U.S. managed-care and Medicaid specialist. The focus for investors is the current analyst consensus on earnings and valuation for the health insurance stock.

How analysts view Centene today

On Wall Street, Centene is typically covered by a broad panel of U.S. and international research houses, including Goldman Sachs, JPMorgan, Morgan Stanley, Citi and Bank of America. Their reports track the company’s Medicaid, Medicare Advantage and exchange businesses, with estimates for revenue growth, margins and member trends.

Across these houses, Centene is commonly evaluated against U.S. managed-care peers such as UnitedHealth Group, Elevance Health and Humana. Analysts monitor contract renewals with U.S. states, medical cost trends and regulatory developments when setting their ratings and price targets, providing a structured consensus picture for the stock.

Earnings expectations and valuation focus

For the current financial year, research models for Centene generally include expectations for mid- to high-single-digit revenue growth, supported by Medicaid and Medicare enrollment and exchange-plan membership. Operating margins are followed closely, as medical cost ratios and administrative efficiency drive earnings per share outcomes.

Valuation discussions on Centene often reference metrics such as the forward price-to-earnings multiple and enterprise value to earnings before interest, taxes, depreciation and amortization, compared with larger peers UnitedHealth Group and Elevance Health. Investors look at whether Centene trades at a discount or premium to this group, given its more focused Medicaid footprint.

How Centene makes its money

Centene’s core business is managed health care for government-sponsored programs in the United States. The company administers Medicaid plans for U.S. states, offers Medicare Advantage and Medicare prescription drug plans, and provides health insurance for individuals through Affordable Care Act marketplace exchanges.

Where the Centene shares trade

Centene Corp. (US15133V1035) shares trade on 2026-06-30, 10:30 on the NYSE in U.S. dollars. The stock is part of the U.S. managed-care sector, alongside names such as UnitedHealth Group and Elevance Health.

Centene Corp. at a glance

• Company: Centene Corporation
• ISIN: US15133V1035
• WKN: 766458
• Ticker: CNC
• Trading venue: NYSE
• Price (as of 2026-06-30, 10:30): [latest price] USD
• Market cap: [latest market cap] USD (as of 2026-06-30)
• Sector / industry: Health Care / Managed Care
• Index membership: S&P 500
• Next earnings date: not officially scheduled

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of an offer to buy or sell any financial instrument. All data points and assessments are based on publicly available information believed to be reliable at the time of review, but accuracy and completeness cannot be guaranteed. Investors should conduct their own research and consider their individual financial situation, risk tolerance and investment objectives before making any investment decisions.